Search for dissertations about: "nstemi"
Showing result 1 - 5 of 13 swedish dissertations containing the word nstemi.
-
1. Identification of pathophysiological and prognostic biomarkers in different types of myocardial infarction
Abstract : The pathophysiological mechanisms of myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) are largely unknown. Analogous, differences in pathobiology between ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) are incompletely understood. READ MORE
-
2. Improving outcomes in patients with coronary heart disease using national registers and platelet function testing
Abstract : Introduction: Ischemic heart disease is the leading cause of death worldwide. The aims of this thesis were to evaluate different contemporary approaches in coronary care with regard to mortality and myocardial infarction. READ MORE
-
3. Clinical relevance of high-sensitive Troponin T in cardiovascular disease
Abstract : Background and aims: Troponin T (hs-cTnT) is a cardiac damage marker used in the diagnosis of non-ST segment elevation myocardial infarction (NSTEMI) and for prognostic assessment. Clinical decision-making should ideally be based on evidence. READ MORE
-
4. Point-of-care testing of platelet P2Y12-inhibition in patients with acute coronary syndrome
Abstract : Background: The point-of-care platelet function test Plateletworks® has been shown to identify patients with high platelet aggregation despite P2Y12 inhibition, also known as high-on-treatment platelet reactivity (HPR), who have increased risk for ischemic cardiovascular events. However, this platelet function assay has not been sufficiently validated. READ MORE
-
5. Platelet Inhibition, Revascularization, and Risk Prediction in Non-ST-elevation Acute Coronary Syndromes
Abstract : Cardiovascular disease is the leading cause of death worldwide and ischemic heart disease is the most common manifestation. Despite improved outcomes during the last decades, patients with acute coronary syndromes (ACS) are still at substantial risk of recurrent ischemic events and mortality. READ MORE